| 24. A clinical trial is being conducted. Under the agreement between the sponsoring pharmaceutical company and the department, the research results must be provided to the sponsor before any publication. |
| # | Response Date | Comment |
| 1. | Mon, 2/26/07 10:18 PM | No COI as long as the research can still be published, even if a negative resulty. |
| 2. | Tue, 3/13/07 11:01 PM | Depends on what the sponsor does with results. Do they modify or withhold them, or just review before publication? |
| 3. | Tue, 3/13/07 11:58 PM | Okay so long as it can be published freely by dept. |
| 4. | Wed, 3/14/07 12:13 AM | Providing results is not the same as control of analysis or publication |
| 5. | Wed, 3/14/07 12:23 AM | if the results are subject modification, vs. a first look at the findings |
| 6. | Wed, 3/14/07 12:31 AM | As long as the pharmaceutical company does not have the right to refuse publication or modify content, there should be no COI. |
| 7. | Wed, 3/14/07 12:34 AM | Not a COI if drug company has no control over content or publication, but this is highly suspect if they have any control over dollars at the time or could block publication. |
| 8. | Wed, 3/14/07 12:36 AM | Can the pharmaceutical company alter the results or their publication? |
| 9. | Wed, 3/14/07 1:44 AM | Depends on any restrictions on publication |
| 10. | Wed, 3/14/07 2:31 AM | on whether the sponsor has the right to censor or withhold publication; if the sponsor has the right to censor or prohibit publication if the results are not favorable, the conflict is very serious |
| 11. | Wed, 3/14/07 3:26 AM | No COI providng department has the final say on the publication |
| 12. | Wed, 3/14/07 12:59 PM | no coi as long as the company puts no restrictions on editing or publishing regardless of results |
| 13. | Wed, 3/14/07 1:43 PM | It depends upon whether the underlying data (both negative and positive) is made public (published) in a reasonable time-frame. If not, this is a serious conflict of interest. |
| 14. | Wed, 3/14/07 1:59 PM | if the sponsor has authority to prevent researcher from publishing, a serious COI--otherwise not. |
| 15. | Wed, 3/14/07 2:24 PM | any contact between researcher and company is possible |
| 16. | Wed, 3/14/07 2:35 PM | Would the sponsor also exercise editorial rights over the publication of the data? |
| 17. | Wed, 3/14/07 3:59 PM | depends if the company demands editorial or other influence on the publication |
| 18. | Wed, 3/14/07 10:10 PM | is publication still allowed no matter the results? |
| 19. | Thu, 3/15/07 5:12 PM | It depends on whether or not the agreement provides any special rights to the company to oversee or control the findings beyond simple provision of results. |
| 20. | Mon, 3/19/07 4:24 PM | depends if there is an agreement to publish regardless of the results. |
| 21. | Mon, 3/19/07 5:38 PM | Some Government agencies have the same requirement. This would be a serious problem if the sponsor tried to block publication. |
| 22. | Mon, 3/19/07 8:56 PM | There's a difference between pre-publication disclosure and pre-publication review. |
| 23. | Mon, 3/19/07 9:14 PM | very serious COI if company would then have the ability to stifle the release of the report |
| 24. | Tue, 3/20/07 5:08 AM | provided there is no mutilation or alteration in the final publication to favor the sponsor. |
| 25. | Sun, 3/25/07 11:52 AM | if the sponsor can then block the publication then this is a very serious COI |
| 26. | Mon, 4/23/07 1:35 PM | If the sponsor is allowed to control publication than it is a serious COI.
|
| 27. | Mon, 4/23/07 10:59 PM | It is okay if they are still free to publish the results. It is wrong if the company can cancel publication. |
| 28. | Tue, 4/24/07 1:49 PM | It depends on whether or not they tie their financial sponsorship to whether or not they agree with the results or if they require that they can change what will be published or not. |
| 29. | Tue, 4/24/07 2:02 PM | Very serious if the sponsor can quash publication (see Q#25) |
| 30. | Tue, 4/24/07 6:53 PM | That's enough. I have work to do. |
| 31. | Tue, 4/24/07 7:15 PM | As long as the ultimate decision to publish lies with the investigator and not the company. The company should have the right for scientific input, but not in the ultimate fate of the research. If they disagree, they can always publish their opinion in a scientific commentary. A very serious COI would be posed if they decided the fate of the results. |
| 32. | Tue, 4/24/07 10:02 PM | As long as there is no strings attached with regards to publishing the final data. |
| 33. | Tue, 4/24/07 10:38 PM | No COI if the company does not tamper with the results. |
| 34. | Thu, 4/26/07 9:25 PM | typical but veto over publication would make it serious |
| 35. | Fri, 4/27/07 5:54 PM | This doesn't say the the company controls whether the information actually gets published or not. |
| 36. | Mon, 4/30/07 11:22 PM | As long as the company does not interfere with publication. |
| 37. | Tue, 5/8/07 3:31 PM | ... |
| 38. | Wed, 5/9/07 1:02 PM | Your survey has just exceeded my attention span. Please make it shorter. |
| 39. | Tue, 5/15/07 4:37 PM | If the sponsoring agency requires alteration of data prior to publication that reflects a more positive outcome and is in their favor but not otherwise 100% true - greater COI. |